Skip to main content Accessibility help
  • Print publication year: 2018
  • Online publication date: February 2018

Chapter 5 - Assessment of Endometriosis Before Conception

1.Burney, R. O. and Giudice, L. C. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012;98:511519.
2.Sampson, J. A. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927;3:93110.
3.Meyer, R. Uber den staude der frage der adenomyosites adenomyoma in allgemeinen und adenomyometritis sarcomastosa. Zentralb Gynakol 1919;36:745.
4.Ajossa, S., Mais, V., Guerriero, S., et al. The prevalence of endometriosis in premenopausal women undergoing gynecological surgery. Clin Exp Obstet Gynecol 1994;21:195197.
5.Ceccaroni, M., Clarizia, R., and Placci, A. Pericardial, pleural, and diaphragmatic endometriosis. J Thorac Cardiovasc Surg 2010;140:11891190.
6.Halban, J. Metastatic hysteroadenosisWien Klin Wochenschr1924;37:12051206.
7.Hey-Cunningham, A. J., Fazleabas, A. T., Braundmeier, A. G., et al. Endometrial stromal cells and immune cell populations within lymph nodes in a nonhuman primate model of endometriosis. Reprod Sci 2011;18:747754.
8.Young, V. J., Brown, J. K., Saunders, P. T., and Horne, A. W. The role of the peritoneum in the pathogenesis of endometriosis. Hum Reprod Update 2013;19:558569.
9.Chang, J. H., Au, H. K., Lee, W. C., et al. Expression of the pluripotent transcription factor OCT4 promotes cell migration in endometriosis. Fertil Steril 2013;99:13321339 e1335.
10.Ferrero, S., Arena, E., Morando, A., and Remorgida, V. Prevalence of newly diagnosed endometriosis in women attending the general practitioner. Int J Gynaecol Obstet 2010;110:203207.
11.Tsai, S. J., Wu, M. H., Lin, C. C., et al. Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab 2001;86:57655773.
12.Liu, F, He, L, Liu, Y, et al. The expression and role of oxidative stress markers in the serum and follicular fluid of patients with endometriosis. Clin Exp Obstet Gyn 2013;40:372376.
13.Sealfon, S. C., Weinstein, H., and Millar, R. P. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr Rev 1997;18:180205.
14.DiVasta, A. D. and Laufer, M. R. The use of gonadotropin releasing hormone analogues in adolescent and young patients with endometriosis. Curr Opinion Obstet Gynecol 2013;25:287292.
15.Brown, J., Pan, A., and Hart, R. J. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev 2010:CD008475.
16.Nirgianakis, K., Bersinger, N. A., McKinnon, B., et al. Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment. Eur J Obstet Gynecol Reprod Biol 2013;170:550554.
17.Soares, S. R., Martinez-Varea, A., Hidalgo-Mora, J. J., and Pellicer, A. Pharmacologic therapies in endometriosis: a systematic review. Fertil Steril 2012;98:529555.
18.Kumar, P. and Sharma, A. Gonadotropin-releasing hormone analogs: Understanding advantages and limitations. J Hum Reprod Sci 2014;7:170174.
19.Ferrero, S., Gillott, D. J., Venturini, P. L., and Remorgida, V. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reprod Biol Endocrinol 2011;9:89.
20.Lv, D., Song, H., and Shi, G. Anti-TNF-alpha treatment for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2010: CD008088.
21.Strowitzki, T., Faustmann, T., Gerlinger, C., and Seitz, C. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 2010;151:193198.
22.Dunselman, G. A., Vermeulen, N., Becker, C., et al., ESHRE Endometriosis Guideline Development Group. Management of women with endometriosis. Guideline of the European Society of Human Reproduction and Embriology. 2014 Mar;29(3):400–12. doi: 10.1093/humrep/det457.
23.van der Houwen, L. E., Schreurs, A. M., Schats, R., et al. Efficacy and safety of intrauterine insemination in patients with moderate-to-severe endometriosis. Reprod Biomed Online 2014;28:590598.
24.Coccia, M. E., Rizzello, F., Barone, S., et al. Is there a critical endometrioma size associated with reduced ovarian responsiveness in assisted reproduction techniques? Reprod Biomed Online 2014;29:259266.
25.Sallam, H. N., Garcia-Velasco, J. A., Dias, S., and Arici, A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006:CD004635.
26.Gelbaya, T. A., Gordts, S., D’Hooghe, T. M., et al. Management of endometrioma prior to IVF: compliance with ESHRE guidelines. Reprod Biomed Online 2010;21:325330.
27.Koga, K., Takamura, M., Fujii, T., and Osuga, Y. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril 2015;104:793801.
28.Patacchiola, F., D’Alfonso, A., Di Fonso, A., et al. New horizons in the non-invasive diagnosis of endometriosis. Clin Exp Obstet Gynecol 2013;40:524530.
29.Brown, J. and Farquhar, C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Review 2014:CD009590.
30.Tamura, H., Takasaki, A., Nakamura, Y., et al. A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis. J Ovarian Res 2014;7:100.
31.Polat, M., Yarali, I., Boynukalin, K., and Yarali, H. In vitro fertilization for endometriosis-associated infertility. Women’s Health 2015;11:633641.
32.Practice Committee of the American Society for Reproductive M. Endometriosis and Infertility: A committee opinion. Fertil Steril 2012;98:591598.
33.Ferrero, S., Scala, C., Racca, A., et al. Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: a case-control study. Fertil Steril 2015;103:12361243.
34.Somigliana, E., Benaglia, L., Paffoni, A., et al. Risks of conservative management in women with ovarian endometriomas undergoing IVF. Hum Reprod Update 2015;21:486499.
35.Guo, Y. H., Lu, N., Zhang, Y., et al. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone. Contemp Clin Trials 2012;33:12061210.